The effect of midazolam on persistent postoperative nausea and vomiting

Anaesthesia and Intensive Care

Volumn 27, Issue 1, 1999, Pages 38-40

  Di Florio, T ^a   Goucke, C R ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Anaesthesia; Anti emetics: midazolam; Complications: nausea, vomiting

Indexed keywords

ANTIEMETIC AGENT; BENZODIAZEPINE DERIVATIVE; MIDAZOLAM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0033016264     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9902700107     Document Type: Article

References (18)

1. Cohen MM, Duncan PG, DeBoer DP, Tweed WA. The postoperative interview: Assessing risk factors for nausea and vomiting. Anesth Analg 1994; 78:7-16.
2. Koivuranta M, Laara E, Snare L, Alahuhta S. A survey of postoperative nausea and vomiting. Anaesthesia 1997; 52:443-449.
3. Hemandez Conte AT. Postoperative nausea and vomiting: a review of antiemetic pharmacological interventions. Anaesth Pharmacol Physiol Rev 1996; 4:57-65.
4. Alexander R, Lovell T, Seingury D, Jones RM. Comparison of ondansetron and droperidol in reducing postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia 1995; 50:1086-1088.
5. Olynyk JK, Cullen SR, Leahy MI. Midazolam: an effective antiemetic for cytotoxic chemotherapy. Med J Aust 1989; 150:466.
6. Di Florio T. The use of midazolam for persistent postoperative nausea and vomiting. Anaesth Intensive Care 1992; 20:383-386.
7. Korttila K. The study of postoperative nausea and vomiting. Br J Anaesth 1992; 69:20S-23S.
8. Watcha MF, White PF. Postoperative nausea and vomiting. Anesthesiology 1992; 77:162-184.
9. Forrest JB, Cahalan MK, Rehder K et al. Multicentre study of general anesthesia. Anesthesiology 1990; 72:262-268.
10. Matson A, Palazzo M. Postoperative nausea and vomiting. In: Adams AP, Cashman JN, eds. Recent Advances Anesth and Analge 1995; 19: 107-126.
11. Gilliland HEM, Prasad BK, Mirakhur RK, Fee JPH. An investigation of the potential morphine sparing effect of midazolam. Anaesthesia 1996; 51:808-811.
12. Egan M, Ready LB, Nessly M, Greer BE. Self-administration of midazolam for postoperative anxiety: a double blinded study. Pain 1992; 49:3-8.
13. Reid MS, Herrera-Marschitz M, Hokfelt T, Terenius L, Ungerstedt U. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphan A and substance P. Eur J Pharmacol 1988; 147:411.
14. Gruen RJ, Freidhoff AJ, Coale A, Moghaddam B. Tonic inhibition of striatal dopamine transmission: effects of benzodiazepine and GABA A receptor antagonists on extracellular dopamine levels. Brain Res 1992; 599:51.
15. Takada K, Murai T, Kanayama T, Koshikawa N. Effects of midazolam and flunitrazepam on the release of dopamine from rat striatum measured by in vivo microdialysis. Br J Anaesth 199-33; 70: 181-185.
16. Racke K, Schwore H, Kilbinger H. The pharmacology of 5HT release from enterochromaffin cells. In: Reynolds WM, Andrews PLR, Davis CJ, eds. Serotonin and the Scientific Basis of Antiemetic Therapy. Oxford Clinical Communications 1995; pp 84-89.
17. Parker RMC, Bentley KR, Barnes NM. Allosteric modulation of 5HT3 receptors: focus on alcohols and anaesthetic agents. Trends Pharmacol Sci 1996; 17:95-99.
18. Di Florio T. An update on postoperative nausea and vomiting. In: Keneally J, Jones M, eds. Australasian Anaesthesia Australian and New Zealand College of Anaesthetists, Melbourne Vic 1996; 155-159.